Literature DB >> 20549175

[Intraoperative parathyroid hormone determination for primary hyperparathyroidism].

K Lorenz1, H Dralle.   

Abstract

Intraoperative parathyroid hormone measurement (IOPTH) has proved to be an important promoter for focused and minimally invasive parathyroidectomy procedures in primary hyperparathyroidism. IOPTH enables multiglandular disease to be excluded with a high degree of certainty at the time of operation. The choice of the cut-off value for IOPTH as the criterion for success is of utmost importance with respect to the prognosis for operative success (biochemical healing). Advantages and disadvantages of the variety of existing IOPTH success criteria are confusing and their assessment is contradictory. Particularly with respect to cost-benefit aspects the standard application of IOPTH as "biochemical frozen section" even in conventional open parathyroidectomy remains a matter of controversy. This article gives an up-date on current knowledge and provides practical guidelines for clinical use of IOPTH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20549175     DOI: 10.1007/s00104-009-1885-7

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  31 in total

1.  Minimally invasive video-assisted parathyroidectomy: multiinstitutional study.

Authors:  K Lorenz; P Miccoli; J M Monchik; M Düren; H Dralle
Journal:  World J Surg       Date:  2001-06       Impact factor: 3.352

2.  Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients.

Authors:  Bill Chiu; Cord Sturgeon; Peter Angelos
Journal:  Arch Surg       Date:  2006-05

3.  Novel criteria for parathyroid hormone levels in parathyroid hormone-guided parathyroid surgery.

Authors:  Robert de Vos tot Nederveen Cappel; Nicole Bouvy; Wouter de Herder; Yolanda de Rijke; Hans van Toor; Jaap Bonjer
Journal:  Arch Pathol Lab Med       Date:  2007-12       Impact factor: 5.534

4.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

5.  Is minimally invasive parathyroidectomy without QPTH monitoring justified?

Authors:  Philipp Riss; Christian Scheuba; Reza Asari; Christian Bieglmayer; Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2009-05-14       Impact factor: 3.445

Review 6.  Minimally invasive parathyroidectomy: benefits and requirements of localization, diagnosis, and intraoperative PTH monitoring. long-term results.

Authors:  Douglas L Fraker; Hasly Harsono; Robert Lewis
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

Review 7.  The role of intraoperative measurement of parathyroid hormone in parathyroid surgery.

Authors:  Phillip K Pellitteri
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2008-10-30       Impact factor: 1.538

8.  Intraoperative PTH monitoring during parathyroidectomy: the need for stricter criteria to detect multiglandular disease.

Authors:  Celestino Pio Lombardi; Marco Raffaelli; Emanuela Traini; Enrico Di Stasio; Cinzia Carrozza; Carmela De Crea; Cecilia Zuppi; Rocco Bellantone
Journal:  Langenbecks Arch Surg       Date:  2008-07-24       Impact factor: 3.445

9.  Surgery for patients with primary hyperparathyroidism and negative sestamibi scintigraphy--a feasibility study.

Authors:  Mark Thier; Erik Nordenström; Anders Bergenfelz; Johan Westerdahl
Journal:  Langenbecks Arch Surg       Date:  2009-06-23       Impact factor: 3.445

Review 10.  Surgical strategy for sporadic primary hyperparathyroidism an evidence-based approach to surgical strategy, patient selection, surgical access, and reoperations.

Authors:  Radu Mihai; Marcin Barczynski; Maurizio Iacobone; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2009-06-25       Impact factor: 3.445

View more
  7 in total

1.  Current trends in surgery for renal hyperparathyroidism (RHPT)--an international survey.

Authors:  Philipp Riss; Reza Asari; Christian Scheuba; Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2012-11-11       Impact factor: 3.445

2.  [Rejection of unilateral parathyroidectomy for primary hyperparathyroidism?].

Authors:  K Lorenz
Journal:  Chirurg       Date:  2012-09       Impact factor: 0.955

Review 3.  [Pathology of parathyroid glands: Practical aspects for routine pathological investigations].

Authors:  S-Y Sheu-Grabellus; K W Schmid
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

4.  Risk factors for "PTH spikes" during surgery for primary hyperparathyroidism.

Authors:  Philipp Riss; Christoph Krall; Christian Scheuba; Christian Bieglmayer; Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2013-07-05       Impact factor: 3.445

Review 5.  The current status of intraoperative iPTH assay in surgery for primary hyperparathyroidism.

Authors:  Marcin Barczyński; Filip Gołkowski; Ireneusz Nawrot
Journal:  Gland Surg       Date:  2015-02

6.  [Diagnostics and treatment of primary hyperparathyroidism].

Authors:  C Nies
Journal:  Chirurg       Date:  2017-12       Impact factor: 0.955

7.  Applicability of a shortened interpretation model for intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism in an endemic goiter region.

Authors:  Philipp Riss; Angelika Geroldinger; Andreas Selberherr; Lindsay Brammen; Julian Heidtmann; Christian Scheuba
Journal:  Eur Surg       Date:  2018-07-11       Impact factor: 0.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.